Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128

1.

Illicit upregulation of serotonin signaling pathway in adrenals of patients with high plasma or intraadrenal ACTH levels.

Le Mestre J, Duparc C, Reznik Y, Bonnet-Serrano F, Touraine P, Chabre O, Young J, Suzuki M, Sibony M, Gobet F, Stratakis CA, Raverot G, Bertherat J, Lefebvre H, Louiset E.

J Clin Endocrinol Metab. 2019 May 10. pii: jc.2019-00425. doi: 10.1210/jc.2019-00425. [Epub ahead of print]

PMID:
31074783
2.

High Prevalence of a Hotspot of Noncoding Somatic Mutations in Intron 6 of GPR126 in Bladder Cancer.

Garinet S, Pignot G, Vacher S, Le Goux C, Schnitzler A, Chemlali W, Sirab N, Barry Delongchamps N, Zerbib M, Sibony M, Allory Y, Damotte D, Bieche I.

Mol Cancer Res. 2019 Feb;17(2):469-475. doi: 10.1158/1541-7786.MCR-18-0363. Epub 2018 Nov 6.

PMID:
30401719
3.

Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma.

Job S, Draskovic I, Burnichon N, Buffet A, Cros J, Lépine C, Venisse A, Robidel E, Verkarre V, Meatchi T, Sibony M, Amar L, Bertherat J, de Reyniès A, Londoño-Vallejo A, Favier J, Castro-Vega LJ, Gimenez-Roqueplo AP.

Clin Cancer Res. 2019 Jan 15;25(2):760-770. doi: 10.1158/1078-0432.CCR-18-0139. Epub 2018 Oct 9.

PMID:
30301828
4.

Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer and Its Impact on Surgical Morbidity and Oncological Outcomes: A Real-World Experience.

Nguyen TT, Huillard O, Dabi Y, Anract J, Sibony M, Zerbib M, Xylinas E.

Front Surg. 2018 Sep 19;5:58. doi: 10.3389/fsurg.2018.00058. eCollection 2018.

5.

Clinicopathological description of 43 oncocytic adrenocortical tumors: importance of Ki-67 in histoprognostic evaluation.

Renaudin K, Smati S, Wargny M, Al Ghuzlan A, Aubert S, Leteurtre E, Patey M, Sibony M, Sturm N, Tissier F, Amar L, Bertherat J, Berthozat C, Chabre O, Do Cao C, Haissaguerre M, Pierre P, Briet C, Vezzosi D, Lifante JC, Pattou F, Mirallie E, Baudin E, Cariou B, Libe R, Drui D; for Comete-Cancer Network.

Mod Pathol. 2018 Nov;31(11):1708-1716. doi: 10.1038/s41379-018-0077-8. Epub 2018 Jun 19.

PMID:
29921900
6.

SWI/SNF protein expression status in fumarate hydratase-deficient renal cell carcinoma: immunohistochemical analysis of 32 tumors from 28 patients.

Agaimy A, Amin MB, Gill AJ, Popp B, Reis A, Berney DM, Magi-Galluzzi C, Sibony M, Smith SC, Suster S, Trpkov K, Hes O, Hartmann A.

Hum Pathol. 2018 Jul;77:139-146. doi: 10.1016/j.humpath.2018.04.004. Epub 2018 Apr 22.

PMID:
29689242
7.

Reversal of a Blunted Follicle-Stimulating Hormone by Chemotherapy in an Inhibin B-Secreting Adrenocortical Carcinoma.

Espiard S, Lahlou N, Sibony M, Louiset E, Bienvenu M, Bertherat J, Dousset B, Groussin L, Libé R.

J Endocr Soc. 2017 Jan 12;1(1):46-50. doi: 10.1210/js.2016-1009. eCollection 2017 Jan 1.

8.

Detection and monitoring of circulating tumor DNA in adrenocortical carcinoma.

Garinet S, Nectoux J, Neou M, Pasmant E, Jouinot A, Sibony M, Orhant L, Pipoli da Fonseca J, Perlemoine K, Bricaire L, Groussin L, Soubrane O, Dousset B, Libe R, Letourneur F, Bertherat J, Assié G.

Endocr Relat Cancer. 2018 Mar;25(3):L13-L17. doi: 10.1530/ERC-17-0467. Epub 2017 Dec 6. No abstract available.

PMID:
29212777
9.

mRNA Expression levels of genes involved in antitumor immunity: Identification of a 3-gene signature associated with prognosis of muscle-invasive bladder cancer.

Le Goux C, Vacher S, Pignot G, Sibony M, Barry Delongchamps N, Terris B, Piaggio E, Zerbib M, Damotte D, Bieche I.

Oncoimmunology. 2017 Aug 14;6(11):e1358330. doi: 10.1080/2162402X.2017.1358330. eCollection 2017.

10.

Impact of body mass index on the oncological outcomes of patients treated with radical nephroureterectomy for upper tract urothelial carcinoma.

Dabi Y, El Mrini M, Duquesnes I, Delongchamps NB, Sibony M, Zerbib M, Xylinas E.

World J Urol. 2018 Jan;36(1):65-71. doi: 10.1007/s00345-017-2095-4. Epub 2017 Oct 14.

PMID:
29032451
11.

[Pathological findings of visible and non-visible tumors on multiparametric magnetic resonance imaging (MRI) prior to radical prostatectomy].

Rivière A, Cornud F, Beuvon F, Sibony M, Legmann P, Barry Delongchamps N.

Prog Urol. 2017 Sep;27(10):536-542. doi: 10.1016/j.purol.2017.07.004. Epub 2017 Sep 1. French.

PMID:
28867582
12.

Programmed death-1 (PD-1) receptor/PD-1 ligand (PD-L1) expression in fumarate hydratase-deficient renal cell carcinoma.

Alaghehbandan R, Stehlik J, Trpkov K, Magi-Galluzzi C, Condom Mundo E, Pane Foix M, Berney D, Sibony M, Suster S, Agaimy A, Montiel DP, Pivovarcikova K, Michalova K, Daum O, Ondic O, Rotterova P, Dusek M, Hora M, Michal M, Hes O.

Ann Diagn Pathol. 2017 Aug;29:17-22. doi: 10.1016/j.anndiagpath.2017.04.007. Epub 2017 Apr 24.

PMID:
28807336
13.

Eosinophilic Solid and Cystic Renal Cell Carcinoma (ESC RCC): Further Morphologic and Molecular Characterization of ESC RCC as a Distinct Entity.

Trpkov K, Abou-Ouf H, Hes O, Lopez JI, Nesi G, Comperat E, Sibony M, Osunkoya AO, Zhou M, Gokden N, Leroy X, Berney DM, Werneck Cunha I, Musto ML, Athanazio DA, Yilmaz A, Donnelly B, Hyndman E, Gill AJ, McKenney JK, Bismar TA.

Am J Surg Pathol. 2017 Oct;41(10):1299-1308. doi: 10.1097/PAS.0000000000000838.

PMID:
28786877
14.

From benign adrenal incidentaloma to adrenocortical carcinoma: an exceptional random event.

Belmihoub I, Silvera S, Sibony M, Dousset B, Legmann P, Bertagna X, Bertherat J, Assié G.

Eur J Endocrinol. 2017 Jun;176(6):K15-K19. doi: 10.1530/EJE-17-0037. Epub 2017 Mar 27.

PMID:
28348073
15.

Correlation between messenger RNA expression and protein expression of immune checkpoint-associated molecules in bladder urothelial carcinoma: A retrospective study.

Le Goux C, Damotte D, Vacher S, Sibony M, Delongchamps NB, Schnitzler A, Terris B, Zerbib M, Bieche I, Pignot G.

Urol Oncol. 2017 May;35(5):257-263. doi: 10.1016/j.urolonc.2017.01.014. Epub 2017 Mar 11.

PMID:
28291636
16.

DNA Methylation Is an Independent Prognostic Marker of Survival in Adrenocortical Cancer.

Jouinot A, Assie G, Libe R, Fassnacht M, Papathomas T, Barreau O, de la Villeon B, Faillot S, Hamzaoui N, Neou M, Perlemoine K, Rene-Corail F, Rodriguez S, Sibony M, Tissier F, Dousset B, Sbiera S, Ronchi C, Kroiss M, Korpershoek E, de Krijger R, Waldmann J, K D, Bartsch, Quinkler M, Haissaguerre M, Tabarin A, Chabre O, Sturm N, Luconi M, Mantero F, Mannelli M, Cohen R, Kerlan V, Touraine P, Barrande G, Groussin L, Bertagna X, Baudin E, Amar L, Beuschlein F, Clauser E, Coste J, Bertherat J.

J Clin Endocrinol Metab. 2017 Mar 1;102(3):923-932. doi: 10.1210/jc.2016-3205.

PMID:
27967600
17.

Tim-3 Expression on Tumor-Infiltrating PD-1+CD8+ T Cells Correlates with Poor Clinical Outcome in Renal Cell Carcinoma.

Granier C, Dariane C, Combe P, Verkarre V, Urien S, Badoual C, Roussel H, Mandavit M, Ravel P, Sibony M, Biard L, Radulescu C, Vinatier E, Benhamouda N, Peyromaure M, Oudard S, Méjean A, Timsit MO, Gey A, Tartour E.

Cancer Res. 2017 Mar 1;77(5):1075-1082. doi: 10.1158/0008-5472.CAN-16-0274. Epub 2016 Nov 21.

18.

[Bladder tumor histo-seminar - case 1: Invasive urothelial carcinoma, high grade and stage T1 extensive].

Sibony M.

Ann Pathol. 2016 Dec;36(6):375-378. doi: 10.1016/j.annpat.2016.09.011. Epub 2016 Nov 9. Review. French. No abstract available.

PMID:
27838078
19.

[Bladder tumor histoseminar - Case 2: Invasive urothelial carcinoma, with lamina propria invasion and micropapillary component].

Sibony M.

Ann Pathol. 2016 Dec;36(6):379-381. doi: 10.1016/j.annpat.2016.09.005. Epub 2016 Nov 9. French. No abstract available.

PMID:
27838077
20.

[A case of urothelial carcinoma with trophoblastic differentiation and review of the literature].

Cazorla A, Sibony M, Pedron P, Munz-Beaugrand C.

Ann Pathol. 2016 Oct;36(5):347-350. doi: 10.1016/j.annpat.2016.06.016. Epub 2016 Sep 15. Review. French.

PMID:
27639773
21.

Tubulocystic Carcinoma of the Kidney With Poorly Differentiated Foci: A Frequent Morphologic Pattern of Fumarate Hydratase-deficient Renal Cell Carcinoma.

Smith SC, Trpkov K, Chen YB, Mehra R, Sirohi D, Ohe C, Cani AK, Hovelson DH, Omata K, McHugh JB, Jochum W, Colecchia M, Amin M, Divatia MK, Hes O, Menon S, Werneck da Cunha I, Tripodi S, Brimo F, Gill AJ, Osunkoya AO, Magi-Galluzzi C, Sibony M, Williamson SR, Nesi G, Picken MM, Maclean F, Agaimy A, Cheng L, Epstein JI, Reuter VE, Tickoo SK, Tomlins SA, Amin MB.

Am J Surg Pathol. 2016 Nov;40(11):1457-1472.

22.

Cystic Epithelial Tumors of the Prostate: One Case Supporting a Continuous Spectrum From Cystadenoma to Cystadenocarcinoma With Ductal Features.

Uguen A, Doucet L, Badic B, Perrouin-Verbe MA, Valeri A, Bail JP, Marcorelles P, Sibony M.

Am J Surg Pathol. 2016 Dec;40(12):1719-1721. No abstract available.

PMID:
27631516
23.

Impact of body mass index on the oncological outcomes of patients treated with radical cystectomy for muscle-invasive bladder cancer.

Dabi Y, Rouscoff Y, Anract J, Delongchamps NB, Sibony M, Saighi D, Zerbib M, Peyraumore M, Xylinas E.

World J Urol. 2017 Feb;35(2):229-235. doi: 10.1007/s00345-016-1852-0. Epub 2016 Jun 6.

PMID:
27272203
24.

Identification by FFPE RNA-Seq of a new recurrent inversion leading to RBM10-TFE3 fusion in renal cell carcinoma with subtle TFE3 break-apart FISH pattern.

Just PA, Letourneur F, Pouliquen C, Dome F, Audebourg A, Biquet P, Vidaud M, Terris B, Sibony M, Pasmant E.

Genes Chromosomes Cancer. 2016 Jun;55(6):541-8. doi: 10.1002/gcc.22356. Epub 2016 Apr 7.

PMID:
26998913
25.

Fumarate Hydratase-deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome.

Trpkov K, Hes O, Agaimy A, Bonert M, Martinek P, Magi-Galluzzi C, Kristiansen G, Lüders C, Nesi G, Compérat E, Sibony M, Berney DM, Mehra R, Brimo F, Hartmann A, Husain A, Frizzell N, Hills K, Maclean F, Srinivasan B, Gill AJ.

Am J Surg Pathol. 2016 Jul;40(7):865-75. doi: 10.1097/PAS.0000000000000617.

PMID:
26900816
26.

[Negative prognostic impact of female gender on oncological outcomes following radical cystectomy].

Dabi Y, Rouscoff Y, Delongchamps NB, Sibony M, Saighi D, Zerbib M, Peyraumore M, Xylinas E.

Prog Urol. 2016 Feb;26(2):83-8. doi: 10.1016/j.purol.2015.12.001. Epub 2016 Jan 12. French.

PMID:
26796347
27.

L'urétéroscopie diagnostique augmente le risque de récidive vésicale après néphro-urétérectomie totale.

Beurrier S, Lanz C, Elalouf V, Barry Delongchamps N, Sibony M, Saighi D, Zerbib M, Peyromaure M, Xylinas E.

Prog Urol. 2015 Nov;25(13):804-5. doi: 10.1016/j.purol.2015.08.176. French. No abstract available.

PMID:
26544371
28.

Implication de la voie PD1/PDL1 et de la voie CTLA4/CD80 dans les tumeurs urothéliales.

Pignot G, Le Goux C, Bieche I, Vacher S, Barry de Longchamps N, Sibony M, Zerbib M.

Prog Urol. 2015 Nov;25(13):762. doi: 10.1016/j.purol.2015.08.096. French. No abstract available.

PMID:
26544291
29.

Évaluation des sous-stadifications T1a/b et T1m/e dans la prédiction du devenir oncologique des patients présentant une tumeur de vessie n'infiltrant pas le muscle.

Lanz C, Bucau M, Beurrier S, Barry Delongchamps N, Saighi D, Zerbib M, Peyromaure M, Sibony M, Xylinas E.

Prog Urol. 2015 Nov;25(13):760. doi: 10.1016/j.purol.2015.08.091. French. No abstract available.

PMID:
26544286
30.

Étude anatomo-clinique rétrospective d'une série de 17 cas de carcinomes rénaux à stroma leiomyomateux identifiant une association forte avec la Sclérose Tubéreuse de Bourneville.

Verkarre V, Leroy X, Sibony M, Mensah A, Timsit M, Richard S, Joly D, Malinge M, Correas J, Mejean A.

Prog Urol. 2014 Nov;24(13):835-6. doi: 10.1016/j.purol.2014.08.115. Epub 2014 Oct 30. French. No abstract available.

PMID:
26461640
31.

L'Epidermal Growth Factor Receptor (EGFR) est une cible thérapeutique pour un sous-groupe de tumeurs de vessie agressives de phénotype de type basal.

Neuzillet Y, Rebouissou S, De Reynies A, Lepage M, Krucker C, Chapeaublanc E, Herault A, Kamoun A, Caillault A, Letouze E, Elarouci N, Decoux Y, Molinie V, Vordos D, Laplanche A, Maille P, Soyeux P, Ofualuka K, Reyal F, Biton A, Sibony M, Paoletti X, Southgate J, Benhamou S, Allory Y, Radvanyi F, Lebret T.

Prog Urol. 2014 Nov;24(13):806. doi: 10.1016/j.purol.2014.08.053. Epub 2014 Oct 30. French. No abstract available.

PMID:
26461580
32.

Eosinophilic, Solid, and Cystic Renal Cell Carcinoma: Clinicopathologic Study of 16 Unique, Sporadic Neoplasms Occurring in Women.

Trpkov K, Hes O, Bonert M, Lopez JI, Bonsib SM, Nesi G, Comperat E, Sibony M, Berney DM, Martinek P, Bulimbasic S, Suster S, Sangoi A, Yilmaz A, Higgins JP, Zhou M, Gill AJ, Przybycin CG, Magi-Galluzzi C, McKenney JK.

Am J Surg Pathol. 2016 Jan;40(1):60-71. doi: 10.1097/PAS.0000000000000508.

PMID:
26414221
33.

Microbial Disruption of Autophagy Alters Expression of the RISC Component AGO2, a Critical Regulator of the miRNA Silencing Pathway.

Sibony M, Abdullah M, Greenfield L, Raju D, Wu T, Rodrigues DM, Galindo-Mata E, Mascarenhas H, Philpott DJ, Silverberg MS, Jones NL.

Inflamm Bowel Dis. 2015 Dec;21(12):2778-86. doi: 10.1097/MIB.0000000000000553.

34.

The 10 Hounsfield units unenhanced computed tomography attenuation threshold does not apply to cortisol secreting adrenocortical adenomas.

Chambre C, McMurray E, Baudry C, Lataud M, Guignat L, Gaujoux S, Lahlou N, Guibourdenche J, Tissier F, Sibony M, Dousset B, Bertagna X, Bertherat J, Legmann P, Groussin L.

Eur J Endocrinol. 2015 Sep;173(3):325-32. doi: 10.1530/EJE-15-0036.

PMID:
26243637
35.

Real-time cancer diagnosis during prostate biopsy: ex vivo evaluation of full-field optical coherence tomography (FFOCT) imaging on biopsy cores.

Lopater J, Colin P, Beuvon F, Sibony M, Dalimier E, Cornud F, Delongchamps NB.

World J Urol. 2016 Feb;34(2):237-43. doi: 10.1007/s00345-015-1620-6. Epub 2015 Jun 23.

PMID:
26100944
36.

Conyza species: distribution and evolution of multiple target-site herbicide resistances.

Matzrafi M, Lazar TW, Sibony M, Rubin B.

Planta. 2015 Jul;242(1):259-67. doi: 10.1007/s00425-015-2306-4. Epub 2015 Apr 26.

PMID:
25912190
37.

Refining the regulatory region upstream of SOX9 associated with 46,XX testicular disorders of Sex Development (DSD).

Hyon C, Chantot-Bastaraud S, Harbuz R, Bhouri R, Perrot N, Peycelon M, Sibony M, Rojo S, Piguel X, Bilan F, Gilbert-Dussardier B, Kitzis A, McElreavey K, Siffroi JP, Bashamboo A.

Am J Med Genet A. 2015 Aug;167A(8):1851-8. doi: 10.1002/ajmg.a.37101. Epub 2015 Apr 21.

38.

Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas.

Castro-Vega LJ, Letouzé E, Burnichon N, Buffet A, Disderot PH, Khalifa E, Loriot C, Elarouci N, Morin A, Menara M, Lepoutre-Lussey C, Badoual C, Sibony M, Dousset B, Libé R, Zinzindohoue F, Plouin PF, Bertherat J, Amar L, de Reyniès A, Favier J, Gimenez-Roqueplo AP.

Nat Commun. 2015 Jan 27;6:6044. doi: 10.1038/ncomms7044.

39.

Molecular subtypes of clear cell renal cell carcinoma are associated with sunitinib response in the metastatic setting.

Beuselinck B, Job S, Becht E, Karadimou A, Verkarre V, Couchy G, Giraldo N, Rioux-Leclercq N, Molinié V, Sibony M, Elaidi R, Teghom C, Patard JJ, Méjean A, Fridman WH, Sautès-Fridman C, de Reyniès A, Oudard S, Zucman-Rossi J.

Clin Cancer Res. 2015 Mar 15;21(6):1329-39. doi: 10.1158/1078-0432.CCR-14-1128. Epub 2015 Jan 12.

40.

SDHD immunohistochemistry: a new tool to validate SDHx mutations in pheochromocytoma/paraganglioma.

Menara M, Oudijk L, Badoual C, Bertherat J, Lepoutre-Lussey C, Amar L, Iturrioz X, Sibony M, Zinzindohoué F, de Krijger R, Gimenez-Roqueplo AP, Favier J.

J Clin Endocrinol Metab. 2015 Feb;100(2):E287-91. doi: 10.1210/jc.2014-1870. Epub 2014 Nov 18.

PMID:
25405498
41.

Oncological outcomes of advanced muscle-invasive bladder cancer with a micropapillary variant after radical cystectomy and adjuvant platinum-based chemotherapy.

Masson-Lecomte A, Xylinas E, Bouquot M, Sibony M, Allory Y, Comperat E, Zerbib M, de la Taille A, Rouprêt M.

World J Urol. 2015 Aug;33(8):1087-93. doi: 10.1007/s00345-014-1387-1. Epub 2014 Sep 2.

PMID:
25179011
42.

Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients.

Gill AJ, Hes O, Papathomas T, Šedivcová M, Tan PH, Agaimy A, Andresen PA, Kedziora A, Clarkson A, Toon CW, Sioson L, Watson N, Chou A, Paik J, Clifton-Bligh RJ, Robinson BG, Benn DE, Hills K, Maclean F, Niemeijer ND, Vlatkovic L, Hartmann A, Corssmit EP, van Leenders GJ, Przybycin C, McKenney JK, Magi-Galluzzi C, Yilmaz A, Yu D, Nicoll KD, Yong JL, Sibony M, Yakirevich E, Fleming S, Chow CW, Miettinen M, Michal M, Trpkov K.

Am J Surg Pathol. 2014 Dec;38(12):1588-602. doi: 10.1097/PAS.0000000000000292.

43.

EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype.

Rebouissou S, Bernard-Pierrot I, de Reyniès A, Lepage ML, Krucker C, Chapeaublanc E, Hérault A, Kamoun A, Caillault A, Letouzé E, Elarouci N, Neuzillet Y, Denoux Y, Molinié V, Vordos D, Laplanche A, Maillé P, Soyeux P, Ofualuka K, Reyal F, Biton A, Sibony M, Paoletti X, Southgate J, Benhamou S, Lebret T, Allory Y, Radvanyi F.

Sci Transl Med. 2014 Jul 9;6(244):244ra91. doi: 10.1126/scitranslmed.3008970.

44.

MET is a potential target across all papillary renal cell carcinomas: result from a large molecular study of pRCC with CGH array and matching gene expression array.

Albiges L, Guegan J, Le Formal A, Verkarre V, Rioux-Leclercq N, Sibony M, Bernhard JC, Camparo P, Merabet Z, Molinie V, Allory Y, Orear C, Couvé S, Gad S, Patard JJ, Escudier B.

Clin Cancer Res. 2014 Jul 1;20(13):3411-21. doi: 10.1158/1078-0432.CCR-13-2173. Epub 2014 Mar 21.

45.

A feminizing adrenocortical carcinoma in the context of a late onset 21-hydroxylase deficiency.

Libé R, Arlt W, Louiset E, Waintrop C, Guibourdenche J, Sibony M, Clauser E, Groussin L.

J Clin Endocrinol Metab. 2014 Jun;99(6):1943-4. doi: 10.1210/jc.2014-1342. Epub 2014 Mar 21. No abstract available.

PMID:
24654754
46.

Can we improve the biopsy quality of upper urinary tract urothelial tumors? Single-center preliminary results of a new biopsy forceps.

Al-Qahtani SM, Legraverend D, Gil-Diez de Medina S, Sibony M, Traxer O.

Urol Int. 2014;93(1):34-7. doi: 10.1159/000354875. Epub 2014 Mar 15.

PMID:
24642765
47.

ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome.

Assié G, Libé R, Espiard S, Rizk-Rabin M, Guimier A, Luscap W, Barreau O, Lefèvre L, Sibony M, Guignat L, Rodriguez S, Perlemoine K, René-Corail F, Letourneur F, Trabulsi B, Poussier A, Chabbert-Buffet N, Borson-Chazot F, Groussin L, Bertagna X, Stratakis CA, Ragazzon B, Bertherat J.

N Engl J Med. 2013 Nov 28;369(22):2105-14. doi: 10.1056/NEJMoa1304603.

48.

[Prognostic factors of upper tract urothelial carcinoma].

Elalouf V, Klap J, Delongchamps NB, Conquy S, Sibony M, Saighi D, Peyromaure M, Flam T, Zerbib M, Xylinas E.

Prog Urol. 2013 Dec;23(16):1382-8. doi: 10.1016/j.purol.2013.04.009. Epub 2013 May 24. Review. French.

PMID:
24274942
49.

PI3K/AKT pathway activation in bladder carcinogenesis.

Calderaro J, Rebouissou S, de Koning L, Masmoudi A, Hérault A, Dubois T, Maille P, Soyeux P, Sibony M, de la Taille A, Vordos D, Lebret T, Radvanyi F, Allory Y.

Int J Cancer. 2014 Apr 15;134(8):1776-84. doi: 10.1002/ijc.28518. Epub 2013 Oct 24.

50.

Hybrid oncocytic/chromophobe renal cell tumours do not display genomic features of chromophobe renal cell carcinomas.

Poté N, Vieillefond A, Couturier J, Arrufat S, Metzger I, Delongchamps NB, Camparo P, Mège-Lechevallier F, Molinié V, Sibony M.

Virchows Arch. 2013 Jun;462(6):633-8. doi: 10.1007/s00428-013-1422-4. Epub 2013 May 25.

PMID:
23708994

Supplemental Content

Loading ...
Support Center